LTGO ▲ +3.2% - Latigo Biotherapeutics, Inc. $LTGO - Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights Latigo Biotherapeutics shares rose 3.2% following the company's release of its second quarter 2026 financial results and business highlights. The market's positive reaction suggests investors responded favorably to the reported metrics or operational progress outlined in the earnings announcement. 03-SEP-2026 04:05 PM ET